ScholarWorks@Korea University: Kang, Eun Joo

Detailed Information

Kang, Eun Joo (강은주)

College of Medicine (Department of Medical Science)

Research Area

Tel 02-2626-3061
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Prognosis:4||nonsmall cell lung cancer:3||chemotherapy:3||prognosis:3||Complication:2||Small cell lung cancer:2||breast cancer:2||Durvalumab:2||cellfree DNA:2||Diabetes mellitus:2||Depressive disorder:2||Prognostic factor:2||Hematopoietic stem cell transplantation:2||Chemotherapy:2||immunotherapy:2||PDL1:2||End of Life Care:1||pulmonary sarcomatoid carcinoma:1||Screening test:1||mRNA expression:1||prognostic indicator:1||Cellfree nucleic acids quantification:1||modes of death:1||nintedanib:1||malignant salivary gland tumors:1||tumorinfiltrating lymphocytes:1||Salivary duct carcinoma (SDC) is a rare:1||followed by another two cycles of chemotherapy (cisplatin 60 mg/m2:1||however:1||Wild type:1||Urinary bladder:1||Secondline chemotherapy:1||Prognostic factors:1||FOLFIRI:1||molecular subtype:1||Therapeutics:1||Locally advanced head and neck squamous cell carcinoma:1||estrogen receptor:1||exemestane:1||safety:1||clinical outcome:1||Tyrosine kinase inhibitors:1||Surgery:1||lung cancer:1||Biomarkers:1||Clinical trial:1||Predictive value:1||Good death:1||active pain control:1||attitudes toward death:1||Attitude:1||patient:1||elderly:1||missense mutation:1||prognostic value:1||vascular endothelial growth factor receptor (VEGFR):1||Salivary gland cancer:1||chest CT indicated recurrence in the right axilla. We initiated ADT with bicalutamide and leuprolide. Five months later:1||Visceral larva migrans:1||Liver:1||Breast cancer:1||ALDH1:1||biologically aggressive:1||Gastric cancer:1||isolated locoregional recurrence:1||Subsequent treatment:1||hydroxymethylglutarylCoA reductase inhibitors:1||Tooth loss:1||predictive biomarker:1||PI3KCA:1||Vascular endothelial growth factor receptors:1||immune cell:1||obstructive lung disease:1||Nonsmallcell lung carcinoma:1||advance directives:1||decisionmaking:1||Prognostic Disclosure to Children:1||Republic of Korea:1||Attitudes toward death:1||caregiver:1||comorbidity:1||cellfree DNA concentration:1||CTLA4:1||clinicians should consider ADT in recurrent or metastatic SDC of ARs.:1||Nonsmall cell lung carcinoma:1||Prognostic marker:1||Irinotecan:1||disease free survival:1||cancer patients:1||coronavirus disease 2019:1||perception:1||Oral health:1||metastatic extramammary Paget's disease:1||progressionfree survival:1||Head and neck squamous cell carcinoma:1||Squamous cell carcinoma:1||Pancreatic neoplasms:1||terminal care:1||Venous thromboembolism:1||Hyponatremia:1||nonsmall cell lung carcinoma:1||epidermal growth factor receptor:1||secondline treatment:1||Primary Pericardial Mesothelioma:1||Cardiac Tamponade:1||Androgen receptors:1||Neoplasm:1||YKL40:1||nonsmall cell lung cancer:1||Aged:1||Head and neck neoplasms:1||tumorinfiltrating lymphocyte:1||Axitinib:1||sequencing:1||mutations:1||Advanced lung cancer:1||Metabolic tumor volume:1||Squamous cell carcinoma of the head and neck:1||Pancreatic cancer:1||Endoflife:1||cancer:1||early palliative care:1||Cisplatin:1||Singleincision technique:1||Skeletalrelated event:1||Androgen receptor antagonist:1||5 FU 750 mg/m2). Posttreatment neck CT indicated that no residual tumor tissue remained:1||Epidermal growth factor receptor:1||Firstline chemotherapy:1||Toxocariasis:1||Thirdline chemotherapy:1||breast neoplasm:1||everolimus:1||Neoplasms:1||Cell cycle pathway:1||Plateletlymphocyte ratio:1||Nintedanib:1||Communication:1||HIV/AIDS:1||Comorbidity:1||Platelet function analyzer:1||lung function:1||life support care:1||passive euthanasia:1||active euthanasia:1||nonsmallcell lung carcinoma:1||Pemetrexed:1||Complications:1||relapsefree survival:1||cisplatin:1||aggressive tumor. Androgen deprivation therapy (ADT) has been shown to have beneficial effects on SDCexpressing androgen receptors (ARs). A 69yearold male with a right neck mass presented to our clinic. Computed tomography (CT) of the neck revealed a mass (6 cm diameter) on the right parotid gland:1||Biliary tract cancer:1||discontinuation:1||survival:1||locally advanced head and neck squamous cell carcinoma:1||Risk:1||adenoid cystic carcinoma:1||axitinib:1||Neutrophillymphocyte ratio:1||Chronic Conditions:1||Locally advanced head and neck cancer:1||Multidisciplinary treatment:1||Strategy:1||Inflammation:1||Total lesion glycolysis:1||Advance care planning:1||Nextgeneration sequencing:1||Molecular targeted therapy:1||Khorana score:1||Pediatric Advance Care Planning:1||Cancer:1||prognostic factors:1||molecular targeted therapy:1||nonsmallcell lung cancer:1||Implantable venous access port:1||pemetrexed:1||Bone metastases:1||the axillar tumor tissue had almost disappeared. Our case demonstrates that ADT is effective for SDC of ARs. Therefore:1||screening:1||brain metastasis:1||proton pump inhibitors:1||immune checkpoint inhibitors:1||Induction chemotherapy:1||gender:1||Neurological Conditions:1||tremelimumab:1||Postprogression survival:1||Bleeding:1||head and neck cancer:1||Pediatric Palliative Care:1||PAS:1||multiplex polymerase chain reaction:1||Axillary vein:1||salivary gland cancer:1||PDL2:1||malignant mesothelioma:1||pericardium:1||and enlarged lymph nodes. Examination of a needle biopsy sample identified SDCexpressing ARs. We performed total parotidectomy with bilateral neck dissection and concurrent postoperative chemoradiotherapy (total 66 Gy) with cisplatin (35 mg/m2):1||duration of treatment:1||immune checkpoint inhibitor:1||longterm survival:1||vaccine:1||artificial intelligenceanalysis:1||overall survival:1||trastuzumab:1||Adenoid cystic carcinoma:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE